Table 1 Effects of compound C1 on blood tests.

From: Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of Apoptosis and inhibition of breast cancer stem cells

Group

HGB (g/dL)

HCT (%)

RBC (106 cells/μL)

MCV (fL)

MCH (pg)

MCHC (g/dL)

RDW (%)

WBC (103cells/μL)

Platelet (103 cells/μL)

Vehicle

15.46 ± 0.12

44 ± 0.00

10.63 ± 0.16

62.31 ± 0.38

17.35± 0.21

34.26 ± 0.15

18.43 ± 0.35

7.53 ± 0.19

998.83 ± 25.43

25 mg/kg

15.27 ± 0.15

44 ± 0.00

10.57 ± 0.19

62.66 ± 0.34

17.82 ± 0.23

34.17 ± 0.24

19.33 ± 0.53

7.45 ± 0.21

983.39 ± 27.52

50 mg/kg

15.20 ± 0.18

43 ± 0.00

10.42 ± 0.22

62.75 ± 0.21

17.53 ± 0.13

34.15 ± 0.17

19.25 ± 0.25

7.38 ± 0.15

995.27 ± 22.32

100 mg/kg

15.25 ± 0.13

43 ± 0.00

10.82 ± 0.17

61.73 ± 0.41

18.51 ± 0.42

34.23 ± 0.29

20.57 ± 0.46

7.25 ± 0.14

1002.72± 26.31

  1. The values are expressed as the mean ± standard deviation (SD). There were no significant differences between the groups. Statistical analysis is defined as significant if *P < 0.05.
Back to article page